The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
The days of blurred lines between investment banks, hedge funds and traditional banks are over.
And that means two things. First, the profits won’t be as juicy. And second, the top sales talent will consequently move to where the bonuses are the most lucrative.
Question is: Where is the “action” moving to?
One destination is the mergers and acquisitions world. And judging by the attention that Cadbury (NYSE: CBY) and Kraft Foods (NYSE: KFT) buyout discussions are getting, you can see why.
Just last week, we heard about Disney’s (NYSE: DIS) takeover of Marvel, and the merger news keeps rolling in.
Looking around the markets, there are few other opportunities for top talent to churn out fantastic bonuses and commission-generating transactions like there are in M&A.
Hedge funds are about to be regulated, investment banks are under government screws, the equities markets look to flatline for the next year. And that’s not even getting into the fundamentals of M&A.
Market capitalizations are way down, the haves (those with cash) and the have-nots are numerous, and the attractiveness of buying the competition grows.
Symbols mentioned in this article: CBY, KFT and DIS.
- Another 430%+ Gain in AIG
- AIG Gives Big Bonuses to Investors
- Hedge Funds & Private Equity & Bears! Oh My!
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed